Unknown

Dataset Information

0

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.


ABSTRACT: Monoclonal antibodies are standard therapeutics for several cancers including the anti-CD20 antibody rituximab for B cell non-Hodgkin lymphoma (NHL). Rituximab and other antibodies are not curative and must be combined with cytotoxic chemotherapy for clinical benefit. Here we report the eradication of human NHL solely with a monoclonal antibody therapy combining rituximab with a blocking anti-CD47 antibody. We identified increased expression of CD47 on human NHL cells and determined that higher CD47 expression independently predicted adverse clinical outcomes in multiple NHL subtypes. Blocking anti-CD47 antibodies preferentially enabled phagocytosis of NHL cells and synergized with rituximab. Treatment of human NHL-engrafted mice with anti-CD47 antibody reduced lymphoma burden and improved survival, while combination treatment with rituximab led to elimination of lymphoma and cure. These antibodies synergized through a mechanism combining Fc receptor (FcR)-dependent and FcR-independent stimulation of phagocytosis that might be applicable to many other cancers.

SUBMITTER: Chao MP 

PROVIDER: S-EPMC2943345 | biostudies-literature | 2010 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


Monoclonal antibodies are standard therapeutics for several cancers including the anti-CD20 antibody rituximab for B cell non-Hodgkin lymphoma (NHL). Rituximab and other antibodies are not curative and must be combined with cytotoxic chemotherapy for clinical benefit. Here we report the eradication of human NHL solely with a monoclonal antibody therapy combining rituximab with a blocking anti-CD47 antibody. We identified increased expression of CD47 on human NHL cells and determined that higher  ...[more]

Similar Datasets

| S-EPMC7509589 | biostudies-literature
| S-EPMC3208297 | biostudies-literature
| S-EPMC5782377 | biostudies-literature
| S-EPMC9310712 | biostudies-literature
| S-EPMC9647079 | biostudies-literature
| S-EPMC3703977 | biostudies-literature
| S-EPMC8058634 | biostudies-literature
| S-EPMC8477956 | biostudies-literature
| S-EPMC3359734 | biostudies-literature
| S-EPMC6035878 | biostudies-literature